Deutsche Märkte geschlossen

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
28,43+0,01 (+0,04%)
Börsenschluss: 05:42PM CET

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

Sektor(en)Healthcare
BrancheDrug Manufacturers - General
Vollzeitmitarbeiter96.931

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. William N. AndersonChairman of the Management Board & CEO8,43MN/A1966
Mr. Wolfgang U. NicklCFO & Member of Management Board1,98MN/A1969
Mr. Heiko W. J. SchipperMember of Management Board & President of the Consumer Health Division1,95MN/A1969
Mr. Stefan OelrichHead of the Pharmaceuticals Division & Member of the Board of Management1,95MN/A1968
Mr. Rodrigo SantosMember of Management Board & President of the Crop Science Division2,17MN/A1973
Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management Board1,33MN/A1964
Dr. Jost ReinhardHead of Investor RelationsN/AN/A1972
Mr. Bernd-Peter BierHead of Group FinanceN/AN/A1967
Mr. Robert LaCazeExecutive VP & Head of the Oncology Strategic Business UnitN/AN/AN/A
Ms. Daniella FosterSVP and Global Head of Public Affairs,Science & Sustainability for Bayer's Consumer Health DivisionN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Corporate Governance

Bayer Aktiengesellschafts ISS Governance QualityScore, Stand 1. März 2024, lautet 6. Die grundlegenden Scores sind Audit: 10, Vorstand: 2, Shareholderrechte: 1, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.